Aroa Biosurgery (Australia) Insiders

Aroa Biosurgery Management Team Effectiveness

The company has return on total asset (ROA) of (0.0586) % which means that it has lost $0.0586 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.108) %, meaning that it generated substantial loss on money invested by shareholders. Aroa Biosurgery's management efficiency ratios could be used to measure how well Aroa Biosurgery manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aroa Biosurgery's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 7.5 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 82.3 M in 2025. Common Stock Shares Outstanding is likely to drop to about 350.4 M in 2025. Net Loss is likely to drop to about (374.2 K) in 2025

Aroa Biosurgery Workforce Comparison

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.

Aroa Biosurgery Benchmark Summation

Aroa Biosurgery Notable Stakeholders

The success or failure of an entity such as Aroa Biosurgery often depends on how effective the management is. Aroa Biosurgery management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aroa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aroa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Aroa Biosurgery's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aroa Biosurgery. Check Aroa Biosurgery's Beneish M Score to see the likelihood of Aroa Biosurgery's management manipulating its earnings.

When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.